Adeshwar Meditex Ltd Stock Price Today (NSE: ADESHWAR)
Adeshwar Meditex Ltd
Fundamental Score
Adeshwar Meditex Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Adeshwar Meditex Ltd share price today is ₹16.30, down 3.72% on NSE/BSE as of 3 August 2026. Adeshwar Meditex Ltd (ADESHWAR) is a Small-cap company in the Healthcare Research, Analytics & Technology sector with a market capitalisation of ₹24.53 (Cr). The 52-week high for ADESHWAR share price is ₹21.80 and the 52-week low is ₹13.00. At a P/E ratio of 19.47x, ADESHWAR is currently trading below its industry average P/E of 39.78x. The company has a Return on Equity (ROE) of 3.35% and a debt-to-equity ratio of 0.16.
Adeshwar Meditex Ltd Share Price Chart — NSE/BSE Historical Performance
Adeshwar Meditex Ltd share price chart: 4.82% return over the past month. 52-week high ₹21.80, 52-week low ₹13.00.
Adeshwar Meditex Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹14.10 | ₹16.30 | ₹14.10 | ₹16.30 | 30.00K (Cr) | |
| ₹16.93 | ₹16.93 | ₹16.93 | ₹16.93 | 0.00 (Cr) | |
| ₹14.55 | ₹16.93 | ₹14.55 | ₹16.93 | 18.00K (Cr) | |
| ₹17.00 | ₹17.00 | ₹17.00 | ₹17.00 | 0.00 (Cr) | |
| ₹17.00 | ₹17.00 | ₹17.00 | ₹17.00 | 0.00 (Cr) | |
| ₹17.00 | ₹17.00 | ₹17.00 | ₹17.00 | 0.00 (Cr) | |
| ₹17.00 | ₹17.00 | ₹17.00 | ₹17.00 | 0.00 (Cr) | |
| ₹17.00 | ₹17.00 | ₹17.00 | ₹17.00 | 0.00 (Cr) | |
| ₹17.00 | ₹17.00 | ₹17.00 | ₹17.00 | 0.00 (Cr) | |
| ₹17.00 | ₹17.00 | ₹17.00 | ₹17.00 | 0.00 (Cr) |
Adeshwar Meditex Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹15.55 | ₹17.00 | ₹14.10 | ₹16.30 | +4.82% | |
| ₹18.41 | ₹18.99 | ₹13.00 | ₹15.55 | -15.54% | |
| ₹15.45 | ₹18.98 | ₹13.50 | ₹18.41 | +19.16% | |
| ₹16.98 | ₹18.99 | ₹13.75 | ₹15.45 | -9.01% | |
| ₹18.00 | ₹18.40 | ₹14.25 | ₹16.98 | -5.67% | |
| ₹18.75 | ₹18.75 | ₹18.75 | ₹18.75 | +0.00% | |
| ₹16.00 | ₹21.00 | ₹13.30 | ₹18.75 | +17.19% | |
| ₹17.70 | ₹17.95 | ₹13.95 | ₹16.00 | -9.60% | |
| ₹18.50 | ₹19.24 | ₹15.52 | ₹17.70 | -4.32% | |
| ₹15.16 | ₹21.80 | ₹15.16 | ₹18.50 | +22.03% | |
| ₹15.76 | ₹19.49 | ₹15.15 | ₹17.25 | +9.45% | |
| ₹18.00 | ₹21.59 | ₹15.60 | ₹18.34 | +1.89% |
AI Research Briefing
Powered by Gemini · 2026-08-01
Deteriorating top-line and severe quarterly profit contraction make this illiquid micro-cap a high-risk trap despite low leverage.
WHAT'S HAPPENING NOW (last 2-4 weeks)
No major catalysts found after live search. The board met in late May 2026 for audited annual results, followed only by routine SEBI SAST and DP regulatory compliance filings. No fresh order contract wins, capacity additions, or acquisitions were reported over the last month.
CORE STORY (THE REAL GAME)
Legacy wound-dressing and medical disposables exporter misclassified under high-tech healthcare analytics. This is a shrinking, low-margin traditional manufacturing micro-cap with zero institutional coverage, not a high-growth med-tech play.
- Latest quarterly sales collapsed 30.44% YoY and net profit crashed 60.45% YoY.
- No major catalysts, contracts, or order wins found after live search in recent weeks.
- Zero institutional holding (FII 0.0%, DII 0.0%) leaves the stock entirely to retail speculation.
- Fresh export order wins in wound dressings or medical disposables.
- Promoter equity infusion or strategic takeover announcement.
- Sharp drop in trading volume triggering an illiquidity lock.
- Micro/SME cap structure with severe illiquidity risk.
- Negative 5-year growth trajectory with Sales CAGR at -3.19% and Profit CAGR at -6.68%.
- Weak capital returns with ROE at 3.35% and ROCE at 5.21%.
Promoter holding stands at 57.68% (up 0.13%), while FII and DII holdings remain flat at 0.0% with zero institutional interest.
Draft National Health Research Policy 2026 prioritizes AI and digital health, leaving low-tech consumable manufacturers with minimal tailwinds.
No major news found after live search.
Yes, 5-year cumulative Free Cash Flow is positive at ₹13.12 Cr.
Expect range-bound movement driven by micro-cap volume spikes until core top-line growth recovers. High risk of capital stagnation.
Primary Thesis Risk
Persistent quarterly revenue decay coupled with severe micro-cap illiquidity.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Adeshwar Meditex Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Adeshwar Meditex Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ADESHWAR across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Attractive Valuation (P/E: 19.47 vs Industry: 39.78)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Conservative Debt Levels (D/E: 0.16)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Balanced Promoter Holding (57.68%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
8 factors identified
Below-Average Return on Equity (3.35%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (5.21%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Profit Decline Concern (-60.45%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-30.44%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-3.19% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Earnings Growth (-12.38% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-6.68% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Adeshwar Meditex Ltd vs Healthcare Research, Analytics & Technology Peers
Peer Comparison - Healthcare Research, Analytics & Technology
Compare Adeshwar Meditex Ltd with 8 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Adeshwar Meditex LtdAdeshwar Medite...Selected✓ ADESHWAR • 543309 | 24.6/100 | ₹16.30₹16 | ₹24.53₹24.53 | 19.47Average 19.5 Average | 3.35%Poor 3.35% Poor | 5.21%Poor 5.21% Poor | 0.16Excellent 0.2 Excellent | -6.68%Poor -6.68% Poor | -3.19%Poor -3.19% Poor | 0.00% |
Syngene International LtdSyngene Interna... SYNGENE • 539268 | 35.4/100 | ₹385.90₹386 | ₹16982.38₹16982.38 | 47.13Average 47.1 Average | 7.71%Poor 7.71% Poor | 9.91%Poor 9.91% Poor | 0.04Excellent 0.0 Excellent | -0.98%Poor -0.98% Poor | 9.45%Good 9.45% Good | 0.30% |
Indegene LtdIndegene Ltd... INDGN • 544172 | 57/100 | ₹515.15₹515 | ₹12302.12₹12302.12 | 29.67Average 29.7 Average | 14.41%Average 14.41% Average | 18.82%Good 18.82% Good | 0.05Excellent 0.1 Excellent | 23.02%Excellent 23.02% Excellent | 29.44%Excellent 29.44% Excellent | 0.39% |
Suven Life Sciences LtdSuven Life Scie... SUVEN • 530239 | 11.4/100 | ₹307.10₹307 | ₹10067.84₹10067.84 | — — | -78.80%Poor -78.80% Poor | -76.92%Poor -76.92% Poor | 0.03Excellent 0.0 Excellent | — — | -12.01%Poor -12.01% Poor | 0.00% |
Vimta Labs LtdVimta Labs Ltd... VIMTALABS • 524394 | 63.6/100 | ₹608.85₹609 | ₹2555.98₹2555.98 | 32.42Average 32.4 Average | 18.87%Good 18.87% Good | 25.23%Excellent 25.23% Excellent | 0.01Excellent 0.0 Excellent | 29.96%Excellent 29.96% Excellent | 14.27%Good 14.27% Good | 0.35% |
Take Solutions LtdTake Solutions ... TAKE • 532890 | 31.2/100 | ₹21.42₹21 | ₹304.13₹304.13 | 71.39Average 71.4 Average | 16.53%Good 16.53% Good | 18.51%Good 18.51% Good | 0.00Excellent 0.0 Excellent | 15.08%Excellent 15.08% Excellent | -41.25%Poor -41.25% Poor | 0.00% |
NOVELIX PHARMACEUTICALS LIMITENOVELIX PHARMAC... NOVELIX • 536565 | 56.9/100 | ₹69.49₹69 | ₹199.32₹199.32 | 77.86Average 77.9 Average | 8.00%Poor 8.00% Poor | 9.98%Poor 9.98% Poor | 0.09Excellent 0.1 Excellent | 22.72%Excellent 22.72% Excellent | 151.69%Excellent 151.69% Excellent | 0.00% |
Bilcare LtdBilcare Ltd... BI • 526853 | 28.9/100 | ₹58.17₹58 | ₹147.94₹147.94 | 26.80Average 26.8 Average | 1.66%Poor 1.66% Poor | 5.56%Poor 5.56% Poor | 3.15Poor 3.1 Poor | 16.32%Excellent 16.32% Excellent | 3.33%Average 3.33% Average | 0.00% |
Vanta Bioscience LtdVanta Bioscienc... VANTABIO • 540729 | 23.9/100 | ₹24.03₹24 | ₹17.99₹17.99 | 163.55Average 163.6 Average | 0.70%Poor 0.70% Poor | 1.19%Poor 1.19% Poor | 1.80Average 1.8 Average | -24.21%Poor -24.21% Poor | -28.62%Poor -28.62% Poor | 0.00% |
Top Healthcare Research, Analytics & Technology Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Syngene International Ltd share price16982.38 Cr
- Indegene Ltd share price12302.12 Cr
- Suven Life Sciences Ltd share price10067.84 Cr
- Vimta Labs Ltd share price2555.98 Cr
- Take Solutions Ltd share price304.13 Cr
Adeshwar Meditex Ltd PE Ratio History
Historical price-to-earnings ratio for ADESHWAR — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹1.39 | ₹26.00 | 18.7x |
| FY 2023 | ₹1.44 | ₹32.00 | 22.2x |
| FY 2022 | ₹0.55 | ₹28.00 | 50.9x |
| FY 2021 | ₹1.16 | ₹38.55 | 33.2x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Adeshwar Meditex Ltd Quarterly Performance
Latest quarterly metrics for ADESHWAR — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-30.44%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-60.45%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
-3.19%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
-6.68%
Compounded annual net profit growth over 5 years
Adeshwar Meditex Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for ADESHWAR — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Adeshwar Meditex Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Adeshwar Meditex Ltd (ADESHWAR) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Adeshwar Meditex Ltd
About ADESHWAR (Adeshwar Meditex Ltd)
Adeshwar Meditex Ltd is a pioneering force in the healthcare landscape, specializing in the research, analytics, and technological advancements surrounding advanced wound care and ...infection control. The company dedicates itself to understanding the intricate biological processes involved in wound healing, leveraging data-driven insights to create innovative solutions that promote faster recovery and minimize patient discomfort. Adeshwar's research division delves into the complexities of microbial resistance and the efficacy of various therapeutic agents, constantly seeking to improve the performance and safety of its product portfolio. By integrating cutting-edge technology with a deep understanding of clinical needs, Adeshwar strives to redefine the standards of wound management, empowering healthcare professionals with effective tools to deliver optimal patient outcomes. The heart of Adeshwar Meditex lies in its commitment to developing next-generation wound care solutions. They achieve this by integrating advanced biomaterials with sophisticated drug delivery systems. This approach allows for precise control over the healing process, tailoring treatments to individual patient needs. The company's analytical capabilities allow them to evaluate the effectiveness of these solutions. This includes assessing their impact on infection rates, scar formation, and overall healing time. Their team of scientists and engineers works tirelessly to translate groundbreaking research into practical applications, fostering a continuous cycle of innovation that addresses the evolving challenges of wound care. Adeshwar Meditex's technological prowess extends beyond product development. It encompasses a comprehensive suite of digital tools designed to enhance the patient experience and improve healthcare delivery. The company is actively exploring the use of artificial intelligence and machine learning to personalize wound care plans, predict potential complications, and optimize treatment protocols. Additionally, Adeshwar is committed to fostering collaboration and knowledge sharing within the healthcare community. This is achieved by providing healthcare professionals with access to valuable data and insights. Ultimately, Adeshwar seeks to be a catalyst for positive change in the world of wound care and infection control.
Company Details
Key Leadership
ADESHWAR Share Price: Frequently Asked Questions
What is the current share price of Adeshwar Meditex Ltd?
Adeshwar Meditex Ltd (ADESHWAR) trades at ₹16.30 on NSE and BSE. Market cap ₹24.53 (Cr). Educational data only.
What is the P/E ratio of Adeshwar Meditex Ltd?
Adeshwar Meditex Ltd has a P/E of 19.47x vs industry average 39.78x.
What is the Bull Run score for Adeshwar Meditex Ltd?
Adeshwar Meditex Ltd has a Bull Run score of 24.6/100 based on 25+ financial parameters.
Does Adeshwar Meditex Ltd pay dividends?
Adeshwar Meditex Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Adeshwar Meditex Ltd?
Adeshwar Meditex Ltd has ROE of 3.35%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Adeshwar Meditex Ltd?
Adeshwar Meditex Ltd has debt-to-equity of 0.16.
Is Adeshwar Meditex Ltd a good investment?
Bull Run gives Adeshwar Meditex Ltd a score of 24.6/100. This is not investment advice — consult a SEBI-registered advisor.